… to the relationship between pneumonia risk and ICS utilization (I 2 = 39.6%, p = 0.043). With
the fixed-effects model, we observed clear increases in pneumonia risk as ICS use rose [RR …

… all types of inhaled corticosteroids (ICSs) would increase the pneumonia risk in patients with
… We aimed to assess the association between ICSs treatment and pneumonia risk in COPD …

… risk of pneumonia in patients with COPD. Hence, ICS should be carefully prescribed in patients
with risk factors for pneumonia … pneumonia according to the use of inhaled corticosteroid (…

… Some previous studies have identified potential risk factors for pneumonia in patients
with chronic obstructive pulmonary disease (COPD) treated with inhaled corticosteroids (ICS), …

… Keywords: case-control; community-acquired pneumonia; adverse effect The use of
inhaled corticosteroids (ICS) previously has been found to increase the risk of pneumonia (1). …

… risk in patients with asthma remains unclear. This review discusses the effect of ICS on
pneumonia … Asthma is associated with an increased risk of pneumonia. Several hypotheses have …

… inhaled corticosteroids (ICSs) as the first line of control therapy. ICSs are associated with an
increased risk of pneumonia in … studies reported an increased risk of pneumonia; however, …

… Inhaled corticosteroids (ICSs) are important in asthma management, but there are concerns
regarding associated risk of pneumonia. … ICS use with pneumonia risk in asthmatic children. …

Inhaled corticosteroids (ICSs) are indicated for the prevention of exacerbations in COPD;
however, a significant proportion of patients at low risk of exacerbations are treated with ICSs. …

… Inhaled corticosteroids (ICS) increase the risk of pneumonia in COPD and commonly are …
use of inhaled corticosteroids (ICS) associated with an enhanced risk of pneumonia in people …